Comparison of metagenomic next-generation sequencing using cell-free DNA and whole-cell DNA for the diagnoses of pulmonary infections

被引:8
作者
He, Ping [1 ]
Wang, Jing [2 ]
Ke, Rui [1 ]
Zhang, Wei [1 ]
Ning, Pu [1 ]
Zhang, Dexin [1 ]
Yang, Xia [1 ]
Shi, Hongyang [1 ]
Fang, Ping [1 ]
Ming, Zongjuan [1 ]
Li, Wei [1 ]
Zhang, Jie [1 ]
Dong, Xilin [1 ]
Liu, Yun [1 ]
Zhou, Jiemin [2 ]
Xia, Han [2 ]
Yang, Shuanying [1 ]
机构
[1] Xi An Jiao Tong Univ, Dept Pulm & Crit Care Med, Affiliated Hosp 2, Xian, Peoples R China
[2] Hugobiotech Co Ltd, Dept Sci Affairs, Beijing, Peoples R China
来源
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY | 2022年 / 12卷
关键词
MNGs; cell-free DNA; whole-cell DNA; pulmonary infection; BALF; PNEUMONIA;
D O I
10.3389/fcimb.2022.1042945
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although the fast-growing metagenomic next-generation sequencing (mNGS) has been used in diagnosing infectious diseases, low detection rate of mNGS in detecting pathogens with low loads limits its extensive application. In this study, 130 patients with suspected pulmonary infections were enrolled, from whom bronchoalveolar lavage fluid (BALF) samples were collected. The conventional tests and mNGS of cell-free DNA (cfDNA) and whole-cell DNA (wcDNA) using BALF were simultaneously performed. mNGS of cfDNA showed higher detection rate (91.5%) and total coincidence rate (73.8%) than mNGS of wcDNA (83.1% and 63.9%) and conventional methods (26.9% and 30.8%). A total of 70 microbes were detected by mNGS of cfDNA, and most of them (60) were also identified by mNGS of wcDNA. The 31.8% (21/66) of fungi, 38.6% (27/70) of viruses, and 26.7% (8/30) of intracellular microbes can be only detected by mNGS of cfDNA, much higher than those [19.7% (13/66), 14.3% (10/70), and 6.7% (2/30)] only detected by mNGS of wcDNA. After in-depth analysis on these microbes with low loads set by reads per million (RPM), we found that more RPM and fungi/viruses/intracellular microbes were detected by mNGS of cfDNA than by mNGS of wcDNA. Besides, the abilities of mNGS using both cfDNA and wcDNA to detect microbes with high loads were similar. We highlighted the advantage of mNGS using cfDNA in detecting fungi, viruses, and intracellular microbes with low loads, and suggested that mNGS of cfDNA could be considered as the first choice for diagnosing pulmonary infections.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Cell-free DNA next-generation sequencing for Mycobacterium tuberculosis obtained from plasma of children with active tuberculosis
    Quan, Shuting
    Tian, Xue
    Sun, Yuting
    Qi, Hui
    Jiao, Weiwei
    Sun, Baixu
    Xu, Fang
    Fang, Min
    Yang, Xuemei
    Zeng, Xi
    Duan, Kun
    Wang, Jichao
    Fu, Xue
    Duan, Li
    Sun, Lin
    Shen, Adong
    BMC PEDIATRICS, 2025, 25 (01)
  • [32] Metagenomic next-generation sequencing for pulmonary infections diagnosis in patients with diabetes
    Siqin Zhang
    Jing Ou
    Yuxue Tan
    Bin Yang
    Yaoyao Wu
    Lin Liu
    BMC Pulmonary Medicine, 23
  • [33] Metagenomic next-generation sequencing for pulmonary infections diagnosis in patients with diabetes
    Zhang, Siqin
    Ou, Jing
    Tan, Yuxue
    Yang, Bin
    Wu, Yaoyao
    Liu, Lin
    BMC PULMONARY MEDICINE, 2023, 23 (01)
  • [34] Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA
    Chae, Young Kwang
    Davis, Andrew A.
    Carneiro, Benedito A.
    Chandra, Sunandana
    Mohindra, Nisha
    Kalyan, Aparna
    Kaplan, Jason
    Matsangou, Maria
    Pai, Sachin
    Costa, Ricardo
    Jovanovic, Borko
    Cristofanilli, Massimo
    Platanias, Leonidas C.
    Giles, Francis J.
    ONCOTARGET, 2016, 7 (40) : 65364 - 65373
  • [35] Separating the signal from the noise in metagenomic cell-free DNA sequencing
    Burnham, Philip
    Gomez-Lopez, Nardhy
    Heyang, Michael
    Cheng, Alexandre Pellan
    Lenz, Joan Sesing
    Dadhania, Darshana M.
    Lee, John Richard
    Suthanthiran, Manikkam
    Romero, Roberto
    De Vlaminck, Iwijn
    MICROBIOME, 2020, 8 (01)
  • [36] Circulating Cell-Free DNA-Based Comprehensive Molecular Analysis of Biliary Tract Cancers Using Next-Generation Sequencing
    Csoma, Szilvia Lilla
    Bedekovics, Judit
    Veres, Gergo
    arokszallasi, Anita
    Andras, Csilla
    Mehes, Gabor
    Mokanszki, Attila
    CANCERS, 2022, 14 (01)
  • [37] Clinical impact of a metagenomic microbial plasma cell-free DNA next-generation sequencing assay on treatment decisions: a single-center retrospective study
    Shishido, Akira A.
    Noe, Myint
    Saharia, Kapil
    Luethy, Paul
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [38] Clinical impact of a metagenomic microbial plasma cell-free DNA next-generation sequencing assay on treatment decisions: a single-center retrospective study
    Akira A. Shishido
    Myint Noe
    Kapil Saharia
    Paul Luethy
    BMC Infectious Diseases, 22
  • [39] Separating the signal from the noise in metagenomic cell-free DNA sequencing
    Philip Burnham
    Nardhy Gomez-Lopez
    Michael Heyang
    Alexandre Pellan Cheng
    Joan Sesing Lenz
    Darshana M. Dadhania
    John Richard Lee
    Manikkam Suthanthiran
    Roberto Romero
    Iwijn De Vlaminck
    Microbiome, 8
  • [40] Detection of Structural Variants in Circulating Cell-Free DNA from Sarcoma Patients Using Next Generation Sequencing
    Mc Connell, Lauren
    Gazdova, Jana
    Beck, Katja
    Srivastava, Shambhavi
    Harewood, Louise
    Stewart, J. P.
    Hubschmann, Daniel
    Stenzinger, Albrecht
    Glimm, Hanno
    Heilig, Christoph E.
    Frohling, Stefan
    Gonzalez, David
    CANCERS, 2020, 12 (12) : 1 - 9